Abstract CT252: A dose escalation phase I study of concurrent GDC-0084 with radiation therapy for patients with solid tumor brain metastases or leptomeningeal metastases harboring PI3K pathway mutations.
Hi needle, the CT252 poster abstract was a conference paper for AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020.
Research Gate has no full text available. To read the full-text of this research, you can request a copy directly from the authors.
This is the Abstract CT252 links from Research Gate and AACR publications..
https://www.researchgate.net/publication/345210544_Abstract_CT252_A_dose_escalation_phase_I_study_of_concurrent_GDC-0084_with_radiation_therapy_for_patients_with_solid_tumor_brain_metastases_or_leptomeningeal_metastases_harboring_PI3K_pathway_mutation
https://cancerres.aacrjournals.org/content/80/16_Supplement/CT252
Regards.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia's paxalisib SNO data
Ann: Kazia's paxalisib SNO data, page-54
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online